Björn Löwenadler

Adjuvare AB is a Swedish company that offers biotechnology research and development services.

Part of Summa Equity AB, Agrisera AB is a Swedish company that produces primary and secondary antibodies for plant and algal cell biology research. The company is based in Vannas, Sweden and provides antibodies for plant and algal research, with prompt delivery worldwide, and reactivity to thousands of species. Agrisera ships worldwide and offers professional technical support. The company was founded in 1985. Erika Gelfgren has been the CEO of the company since 2012.

Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.

Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden.